Green Elephant Biotech is a German-based startup founded in 2021 with the goal of creating a more sustainable and space-efficient future for biotech. The company's slogan, "Adherent cell culture on a small footprint + sustainable lab consumables," encapsulates their focus on sustainability and productivity. Their flagship product, CellScrew®, addresses the global manufacturing capacity crunch in adherent cell cultivation by offering a novel vessel that provides a large growth area on a small footprint and requires less manual labor than common systems, streamlining adherent cell cultivation in cell and gene therapy manufacturing. One of the distinguishing factors of Green Elephant Biotech is its commitment to reducing waste and CO₂ emissions in the biotech industry. Their 96-well plates made from polylactic acid (PLA) serve as a sustainable replacement for commonly used assay plates, as they are manufactured in Germany and made 100% from plant-based materials. The last investment, a Pre Seed Round, occurred on 11 February 2022 and involved BM H Beteiligungs-Managementgesellschaft Hessen as the investor. Overall, Green Elephant Biotech presents itself as a promising player in the biotechnology and manufacturing industries, addressing crucial sustainability challenges and offering innovative, eco-friendly solutions for the biotech sector. Their efforts to revolutionize adherent cell cultivation and introduce sustainable lab consumables indicate strong potential for growth and positive environmental impact.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Pre Seed Round | Unknown | 1 | BM H Beteiligungs-Managementgesellschaft Hessen | 11 Feb 2022 |
No recent news or press coverage available for Green Elephant Biotech.